Modern approaches to the prevention of venous thromboembolic complications in patients with active cancer
Cancer is one of the most significant risk factors for venous thromboembolic complications (VTEC), which combines deep vein thrombosis and pulmonary embolism. Of the many well-known risk factors for VTEC, only cancer is associated with a 4-fold increased risk of venous thrombosis, and in cancer pati...
Saved in:
Main Authors: | Yu. A. Fedotkina (Author), E. P. Panchenko (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABAN
by: Yu. A. Fedotkina, et al.
Published: (2020) -
PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
by: Ju. A. Fedotkina
Published: (2019) -
Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020) -
DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS
by: N. M. Vorobieva, et al.
Published: (2015) -
Characteristics of patients with active cancer and venous thromboembolic complications receiving a chemotherapy treatment cycle (according to the 'real-life' clinical practice of Publicly Funded Health Facility: Moscow City Oncology Hospital No. 62 of Moscow Healthcare Department)
by: J. A. Fedotkina, et al.
Published: (2022)